The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category Financial
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRHSX | 80.75 | 0.71 | +0.89% |
T. Rowe Price Health Sciences | |||
MDOAX | 11.22 | 0.08 | +0.72% |
Morgan Stanley Developing Opportunity A | |||
NSCAX | 50.82 | 0.10 | +0.20% |
Nuveen Small-Cap Value Opps A | |||
RSDFX | 41.21 | -0.06 | -0.15% |
Columbia Dividend Opportunity Inst2 | |||
FBSAX | 39.80 | -0.12 | -0.30% |
Franklin Mutual U.S. Mid Cap Value Adv |
A.I.dvisor indicates that over the last year, PFSAX has been closely correlated with FIDSX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if PFSAX jumps, then FIDSX could also see price increases.
Ticker / NAME | Correlation To PFSAX | 1D Price Change % | ||
---|---|---|---|---|
PFSAX | 100% | -1.65% | ||
FIDSX - PFSAX | 92% Closely correlated | -1.40% | ||
RPFGX - PFSAX | 89% Closely correlated | -1.38% | ||
DVFYX - PFSAX | 89% Closely correlated | -1.37% | ||
PRISX - PFSAX | 88% Closely correlated | -1.59% | ||
JFIFX - PFSAX | 86% Closely correlated | -1.55% | ||
More |